Compare · AKUS vs ASH

AKUS vs ASH

Side-by-side comparison of Akouos Inc. (AKUS) and Ashland Inc. (ASH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both AKUS and ASH operate in Specialty Chemicals (Consumer Discretionary), so they compete in similar markets.
  • ASH carries a market cap of $3.46B.
  • ASH has hit the wire 6 times in the past 4 weeks while AKUS has been quiet.
  • ASH has more recent analyst coverage (25 ratings vs 1 for AKUS).
MetricAKUSASH
Company
Akouos Inc.
Ashland Inc.
Price
-
-
Market cap
-
$3.46B
1M return
-
-
1Y return
-
-
Industry
Specialty Chemicals
Specialty Chemicals
Exchange
NASDAQ
NYSE
IPO
2020
News (4w)
0
6
Recent ratings
1
25
AKUS

Akouos Inc.

Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. Akouos, Inc. was incorporated in 2016 and is based in Boston, Massachusetts.

ASH

Ashland Inc.

Ashland Global Holdings Inc. provides specialty chemical solutions worldwide. The company's Specialty Ingredients segment offers products, technologies, and resources for solving formulation and product-performance challenges. It provides solutions using natural, synthetic, and semisynthetic polymers derived from cellulose ethers, vinyl pyrrolidones, acrylic polymers, polyester and polyurethane-based adhesives, and plant and seed extracts. This segment offers its solutions for the pharmaceutical companies; makers of personal care products, food, and beverages; makers of nutraceuticals and supplements; manufacturers of paint, coatings, and construction materials; packaging and converting markets; and oilfield service companies. Its Intermediates and Solvents produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone that are used as chemical intermediates in the production of engineering polymers and polyurethanes, as well as specialty process solvents used in electronics, pharmaceuticals, water filtration membranes, and others. The company was formerly known as Ashland Inc. and changed its name to Ashland Global Holdings Inc. in September 2016. Ashland Global Holdings Inc. was founded in 1924 and is based in Wilmington, Delaware.